British healthcare real estate investment trust Assura said on Friday it had received a preliminary approach from KKR and UK-based pension fund Universities Superannuation Scheme.
KKR reported Q4 and full-year 2024 with higher-than-expected adjusted EPS of $1.32 but saw a stock drop due to disappointing fee-paying AUM. Management is optimistic for 2025, expecting more exits and deployment opportunities despite potential volatility in the investment environment. KKR's stock is a "buy" due to strong fee-related earnings growth, attractive valuation, and diversified strategies. Coupled with a slight share price dip.
FSK is undervalued, trading at a discount to NAV, with strong NII and a high distribution yield, making it an attractive investment. FSK's portfolio is well-diversified, with 67% senior secured investments and 88.5% floating rate debt, protecting against interest rate changes. FSK is positioned to benefit from expected market conditions in 2025, with opportunities for increased originations and improved credit metrics.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
KKR & Co. Inc. (NYSE:KKR ) Q4 2024 Earnings Conference Call February 4, 2025 10:00 AM ET Company Participants Craig Larson - Partner and Head of IR Scott Nuttall - Co-Chief Executive Officer Robert Lewin - Chief Financial Officer Conference Call Participants Craig Siegenthaler - Bank of America Benjamin Budish - Barclays Alexander Blostein - Goldman Sachs Bill Katz - TD Cowen Glenn Schorr - Evercore ISI Dan Fannon - Jefferies Michael Cyprys - Morgan Stanley Steven Chubak - Wolfe Research Mike Brown - Wells Fargo Vikram Gandhi - HSBC Chris Kotowski - Oppenheimer & Company Patrick Davitt - Autonomous Research Operator Ladies and gentlemen, thank you for standing by. Welcome to KKR's Fourth Quarter 2024 Earnings Conference Call.
KKR & Co's Q4 results benefit from a rise in fee-related earnings and AUM balance. However, a rise in expenses remains a concern.
Global investment firm KKR (KKR -7.81%) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb 4, that topped analysts' consensus estimates. The firm reported an adjusted earnings per share (EPS) of $1.32, beating the estimate of $1.28.
Although the revenue and EPS for KKR & Co. (KKR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
U.S. private equity fund KKR will raise its tender offer price for Fuji Soft shares to 9,850 yen per share from 9,451 yen, above Bain Capital's rival offer of 9,600 yen, the Nikkei business daily reported on Tuesday.
Beyond analysts' top -and-bottom-line estimates for KKR & Co. (KKR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Private-equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of healthcare products to improve its operations, the Wall Street Journal reported on Wednesday citing people familiar with the matter.
Italy's Enel and private equity group KKR are among potential bidders for Britain-based Cubico Sustainable Investments, people with knowledge of the process said.